Abstract
Background
Methods
Results
Conclusion
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to ContraceptionReferences
- Disparities in rates of unintended pregnancy in the United States, 1994 and 2001.Perspect Sex Reprod Health. 2006; 38: 90-96
- The cost of unintended pregnancy in the United States.Contraception. 2007; 75: 168-170
- Use of contraception and use of family planning services in the United States: 1982���2002.Adv Data. 2004; : 1-36
- Economic analysis of contraceptives for women.Contraception. 2003; 68: 3-10
- Preventing unintended pregnancy: the cost-effectiveness of three methods of emergency contraception.Am J Public Health. 1997; 87: 932-937
- Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth.Vital Health Stat 2. 2005; 23: 1-160
- Contraceptive technology.19th rev. ed. Ardent Media, New York (NY)2007
- Pregnancy during the use of levonorgestrel intrauterine system.Am J Obstet Gynecol. 2004; 190: 50-54
- Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation-wide study of 17,360 users.BJOG. 2000; 107: 335-339
- Incidence, trends, and risks of ectopic pregnancy in a population of women.Br Med J (Clin Res Ed). 1981; 282: 15-18
- The pharmacodynamics and efficacy of Implanon. An overview of the data.Contraception. 1998; 58: 91S-97S
- The risk of ectopic pregnancy after tubal sterilization. U.S. Collaborative Review of Sterilization Working Group.N Engl J Med. 1997; 336: 762-767
- The levonorgestrel intrauterine system in contraception.Steroids. 2000; 65: 693-697
- The economic value of contraception: a comparison of 15 methods.Am J Public Health. 1995; 85: 494-503
- Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study.Contraception. 1999; 60: 269-274
- Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.Contraception. 2006; 73: 223-228
- Association between diaphragm use and urinary tract infection.JAMA. 1985; 254: 240-245
- Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial.JAMA. 2001; 285: 2347-2354
- Bleeding patterns of women using extended regimens of the contraceptive vaginal ring.Contraception. 2007; 75: 204-208
- A prospective study of risk factors for symptomatic urinary tract infection in young women.N Engl J Med. 1996; 335: 468-474
- Association between use of spermicide-coated condoms and Escherichia coli urinary tract infection in young women.Am J Epidemiol. 1996; 144: 512-520
- Drug topics red book. Thomson Healthcare, Montvale (NJ)2007
Cerner Multum��� Lexicon, 2007.
- Price Rx drug price and reference tool (Medi-Span Master Drug Database).(Available at) ([Accessed October 2007])
- Pharmacy directory: drug prices.(Available at) ([Accessed March 2008])
- Current procedural terminology (CPT). American Medical Association, Chicago (IL)2007
- Vasectomy in the United States, 1991.Am J Public Health. 1995; 85: 644-649
- Tubal sterilization in the United States, 1994���1996.Fam Plann Perspect. 2001; 33: 161-165
- Ingenix DRG Expert. Ingenix, Eden Prairie (MN)2007
- Abortion incidence and services in the United States in 2000.Perspect Sex Reprod Health. 2003; 35: 6-15
- The accessibility of abortion services in the United States, 2001.Perspect Sex Reprod Health. 2003; 35: 16-24
- Centers for Disease Control and Prevention. Surveillance summaries. MMWR Morb Mortal Wkly Rep. vol. 55, No. SS-11.(Available at) ([Accessed March 2008])
- The healthcare costs of having a baby.(Available at) ([Accessed June 2008])
- Health care expenses for uncomplicated pregnancies. Research Findings No. 27.(Available at) ([Accessed March 2008])
- Hospitalizations related to childbirth, 2003. HCUP Statistical Brief #11. Agency for Healthcare Research and Quality, Rockville, MD.(Available at) ([Accessed November 2007])
- Healthcare Cost and Utilization Project (HCUP).(Available at) ([Accessed June 2008])
- Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study.Contraception. 2003; 67: 87-91
Trussell J, Koenig J, Stewart F, Darroch JE. Medical care cost savings from adolescent contraceptive use. Fam Plann Perspect 1997;29:248���255, 295.
- Long-acting reversible contraception: the effective and appropriate use of long-acting reversible contraception.Royal College of Obstetricians and Gynecologists (RCOG), London (UK)2005
- The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline.Hum Reprod. 2008; 23: 1338-1345
- Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK.Pharmacoeconomics. 2004; 22: 1141-1151
- Economic analysis of long-term reversible contraceptives. Focus on Implanon.Pharmacoeconomics. 2000; 17: 209-221
Trussell J, Vaughan B. Contraceptive failure, method-related discontinuation and resumption of use: results from the 1995 National Survey of Family Growth. Fam Plann Perspect 1999;31:64���72, 93.
- Discontinuation and resumption of contraceptive use: results from the 2002 National Survey of Family Growth.Contraception. 2008; 78: 271-283
- Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia.Fertil Steril. 2003; 79: 963-969
- Overstating cost savings from contraceptive use.Eur J Contracept Reprod Health Care. 2008; 13: 219-221
Article info
Publication history
Footnotes
���This study was supported by a research grant from Bayer HealthCare Pharmaceuticals, Wayne, NJ, USA.